Chinanews client, Beijing, September 6 (Reporter Zhang Ni) Recently, media reports on the shortage of heart stents selected in centralized procurement have aroused concern.
On the 6th, the state-organized medical consumables joint procurement platform announced that the state-organized centralized procurement of coronary stents was implemented steadily, and the supply of selected products was sufficient.
Data map: Medical staff are busy in the operating room.
Photo by Zhang Yao
Recently, some media reported the shortage of selected stents after centralized procurement, and used the title of "Heart Stent Dilemma: There was no money for surgery before, but now there is no money for stents."
In response, the National Organization High-Value Medical Consumables Joint Procurement Office (hereinafter referred to as Joint Procurement) stated that the title of the above report was misleading and disclosed the main status of the implementation of the results of the centralized procurement of coronary stents since January 2021.
Data show that from January to August 2021, medical institutions used 1.1 million selected products (all chrome alloy stents), an increase of 54% compared to the same period last year (710,000) before centralized procurement, and the total use has exceeded the national total. The annual contracted purchase volume (1.07 million), patients actually used the stent after the price reduction.
From January to August 2021, the selected companies have supplied 1.98 million selected stents from the factory, which is more than 1.8 times the annual contracted purchase volume and 1.8 times the actual usage by the hospital.
After deducting the amount used by medical institutions from the factory, the number of circulation and inventory links reached 880,000, and the supply is sufficient.
From a national perspective, brackets of various specifications are in stock.
Before and after centralized procurement, the use of various lengths and diameters and the factory supply structure are basically the same as 2020.
According to reports, the centralized procurement of coronary stents is the first order organized by the state for the centralized procurement of high-value medical consumables. The reform has achieved obvious results: first, the public has benefited significantly; second, doctors’ income has increased; and third, the industrial development environment has been optimized.
According to Beijing's calculations, the average personal burden of patients receiving stent implantation has dropped by 10,000 yuan.
The United Procurement Office stated that centralized and volume procurement has changed the original circulation model, and it needs to strengthen cooperation between production, distribution, and use parties, change long-term habits, adapt to the new mechanism, and expose some problems in the running-in process. Some issues have received special attention due to the reforms: one is that the production, distribution, and users are still in the process of changing the centralized procurement model; the second is the rapid increase in the use of high-priced drug balloons in some hospitals.
Monitoring found that after the price reduction of coronary stents, although the total amount of drug balloons used was not large, the growth rate was very fast. This has a reasonable increase in clinical development, but considering that the price of drug balloons is around 20,000 yuan, others are not excluded. Caused by abnormal factors.
With regard to the supply of the selected stents, the Joint Procurement Office has been working with relevant departments, enterprises and medical institutions to solve the problem, and has achieved significant improvements.
In the next step, the joint procurement office will coordinate with all parties to take targeted measures to further improve the centralized procurement and use of coronary stents.
Including further strengthening the production and distribution capabilities of selected products; promoting medical institutions to improve the degree of refinement of internal management; standardizing the use of drug balloons, etc.
(over)